Late Graft Rejection in Association With T-Large Granular Lymphocyte Expansion of Recipient Origin After Human Leukocyte Antigen-Haploidentical Stem Cell Transplantation: A Case Report

Transplant Proc. 2016 Nov;48(9):3222-3224. doi: 10.1016/j.transproceed.2016.06.037.

Abstract

Background: Large granular lymphocyte (LGL) expansion occasionally occurs after allogeneic stem cell transplantation (allo-SCT), and is thought to be a good prognostic sign that is associated with a lower relapse rate. However, there have been no reports of late graft failure (LGF) due to graft rejection in association with oligoclonal LGL expansion. We herein report a case of LGF associated with the transient expansion of recipient-derived T-LGL after allo-SCT.

Case report: A 65-year-old man underwent peripheral blood stem cell transplantation (PBSCT) from his human leukocyte antigen (HLA)-haploidentical son for the treatment of acute myeloid leukemia, which had evolved from a myelodysplastic syndrome (MDS). Neutrophil engraftment occurred on day 20. A chimerism analysis on day 29 showed both granulocytes and mononuclear cells in the peripheral blood to be completely of donor origin. However, his neutrophil count gradually decreased and a chimerism analysis on day 61 showed that 84% of the patient's T cells were of recipient origin while the granulocytes were 100% donor-derived. His LGLs rapidly increased to 4.01 × 109/L on day 113 and decreased thereafter. The percentage of donor cells in his granulocytes gradually decreased, and the patient's leukocytes were completely replaced by recipient cells on day 177.

Conclusions: The clinical course suggests that the expansion of recipient-derived T-LGLs after allo-SCT can be a sign of graft rejection. Early intervention may be needed if the LGL expansion is recipient-derived.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Chimerism
  • Female
  • Graft Rejection / immunology*
  • Graft vs Host Disease / immunology*
  • HLA Antigens / analysis
  • Histocompatibility Antigens Class II
  • Humans
  • Leukemia, Myeloid, Acute / surgery*
  • Male
  • Peripheral Blood Stem Cell Transplantation / adverse effects*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / pathology*
  • Tissue Donors
  • Transplantation, Homologous / adverse effects

Substances

  • HLA Antigens
  • Histocompatibility Antigens Class II